Punicalagins (Pomegranate).
The large tannins of pomegranate peel. They are not absorbed whole; gut bacteria convert them into urolithins, and that is where the measured activity sits.
Reviewed March 2026
- Category
- Polyphenol
What Punicalagins (Pomegranate) is, and what it does.
- Does it work
- Suits people building an antioxidant or circulation routine. How much urolithin you make depends on your own gut bacteria, so responses vary widely.
- How much to take
- Start with 100mg to 250mg of punicalagins a day, taken with food. Daily consistency matters because the conversion step happens in the colon.
- Time to feel it
- Nothing quick. Urolithins appear in urine within a day or two if you are a converter, while marker changes in trials take six to twelve weeks.
- The first dose
- Quiet in how you feel. In converters, urolithin metabolites start turning up in urine within about a day of the first serving.
- With regular use
- Across weeks, what human trials record are blood markers of oxidative stress and measures of vascular function rather than sensations.
- How well tolerated
- Well tolerated. A high tannin load can be harsh on an empty stomach and binds iron, so take it with food and away from an iron supplement.
- How it feels
- Sharply astringent if you taste it, and otherwise unremarkable to take. The evidence lives on lab reports rather than in daily feel.
- The overlooked benefit
- Some people's gut bacteria make almost no urolithin from the same dose, which explains why one person raves about pomegranate extract and the next shrugs.
250 to 500mg a day is where Punicalagins (Pomegranate) works.
Source: Sahebkar et al. 2017 meta-analysis (8 RCTs). Aviram et al. 2000 Am J Clin Nutr.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Punicalagins (Pomegranate) has emerging evidence. Based on 7+ studies.
- Markers of oxidative stressRandomised trial
- Endothelial functionRandomised trial
- Blood pressure already in the normal rangeMeta-analysis
- Conversion to urolithins by gut bacteriaNarrative review
- Recovery after strenuous exerciseRandomised trial
Questions people ask about Punicalagins (Pomegranate).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Punicalagins are hydrolysed to ellagic acid and then converted by gut bacteria into urolithins, the metabolites that reach tissue. Only part of the population carries the converting organisms, so supplying urolithin A gives the end product directly.
The lactone-ring opening and stepwise dehydroxylation that turn ellagic acid into urolithins are carried out by colonic bacteria, not by human enzymes. The composition of that community is what determines whether punicalagins yield an absorbable metabolite.
Lactobacillus plantarum expresses tannase, which cleaves the galloyl and hexahydroxydiphenoyl esters that make punicalagin such a large molecule. That hydrolysis is the first step toward an absorbable fragment.
After an ellagitannin quenches an oxidant it is left as a phenoxyl radical, and ascorbate donates the electron that returns it to the reduced form. This is the standard antioxidant recycling relationship.
Quercetin and ellagitannin fragments exchange hydrogen atoms within the same phenolic redox pool, so whichever is oxidised first can be restored by the other. They also compete for the same conjugating enzymes, which slows the clearance of both.
Both EGCG and punicalagin carry galloyl groups and share the same phenolic redox chemistry, and both are substrates for catechol-O-methyltransferase. Combining them broadens the polyphenol pool reaching the colon.
Muscadine skin carries its own ellagitannins, so the two extracts feed the same microbial conversion route to urolithins. Together they raise the substrate load for that pathway.
Ellagic acid and the urolithins are heavily glucuronidated on first pass, and piperine inhibits the UGT enzymes that do it. Less conjugation leaves more of the free metabolite in circulation.
Punicalagins are large hydrolysable tannins with many galloyl-type hydroxyl pairs that bind ferric iron in the gut lumen. The resulting complex is poorly taken up, so the two should be spaced apart.
Pomegranate polyphenols damp platelet aggregation responses and EPA shifts eicosanoid output toward the less aggregatory series. Their effects on normal clotting add together.
In the gut lumen punicalagin loses its hexahydroxydiphenoyl groups, which lactonise to ellagic acid. Ellagic acid is then the substrate the colonic microbiota converts further. Any product that lists both is listing a precursor and its immediate hydrolysis product, not two independent actives.
Whether a person produces urolithins at all depends on carrying the right gut bacteria, and metabotype differences between people are large. Fermentable substrates such as inulin change community composition and short-chain fatty acid output. Whether that raises urolithin output in a given person has not been shown, so the row stays at mechanism confidence.
Urolithin production is a microbial trait, not a human enzyme, and the responsible organisms are gut commensals. Supplying a defined strain is a plausible way to support the conversion step. No trial shows that a named commercial strain changes urolithin output in people, which is why this is enabling at Promising and not stronger.
Tannins carry many adjacent phenolic hydroxyls, the classic chelating arrangement for divalent metals. Taken in the same dose, a high-tannin extract can bind zinc in the gut lumen and reduce the fraction available for uptake. Separating the two by a couple of hours is the ordinary formulation answer.
Calcium salts and hydrolysable tannins form insoluble complexes at intestinal pH. The practical effect is reduced solubility for both partners in the same swallow. This is a formulation and timing consideration, not a reason to avoid either ingredient.
Galloyl-rich tannins complex copper in vitro and can reduce its free concentration. Human absorption data for this specific pairing is thin. Flag it as a co-ingestion consideration at low confidence.
Punicalagin binds protein through hydrogen bonding and hydrophobic contact, which is why tannin-rich extracts turn cloudy in protein drinks. Bound polyphenol is measured as less free for hydrolysis and absorption, and the protein aggregates. That is a formulation-stability and measurement point rather than a demonstrated loss of effect.
Adding milk protein to a tannin-rich beverage reduces measurable free polyphenol, a repeatedly demonstrated food-chemistry effect. It changes what is measured in the cup, which is a marker, not a demonstrated loss of a physiological effect. Say which one you have when you use this row.
Soluble fibre gels can adsorb phenolics and delay their release, which shifts where in the gut hydrolysis happens. Slower delivery to the colon is not automatically less conversion; it may be more. Direction is unclear, so the row is modulating.
Dietary nitrate is reduced to nitrite and then nitric oxide, while pomegranate polyphenols have been studied for effects on endothelial nitric oxide handling. The two entry points are different, which is what makes additivity plausible. No combination trial in people has measured it.
Citrulline converts to arginine in the kidney, which supplies the substrate for nitric oxide synthase. Pomegranate polyphenols have been studied for effects on the enzyme's environment rather than its substrate pool. Substrate plus signalling is a reasonable pairing hypothesis and remains untested together.
Alpha-tocopherol works in membranes and its radical is recycled by water-soluble reducing agents. Ellagitannins and their metabolites are aqueous-phase reducers in vitro. The recycling network is established chemistry; a measured benefit from taking the pair is not.
Resveratrol and ellagitannin metabolites are both heavily glucuronidated and sulfated in the intestinal wall and liver. Loading both can change how much of either circulates as free aglycone. The interaction can read as additive on a mechanism chart and competitive in a pharmacokinetic study.
Curcuminoids are extensively glucuronidated in the gut wall, as are ellagitannin metabolites. Co-dosing two high-load substrates can change the free fraction of either. Nothing in people has measured which way it goes for this pair.
Nothing specific on file for Punicalagins (Pomegranate). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Punicalagins (Pomegranate) actually does.
Punicalagins are hydrolysable ellagitannins from pomegranate, built from a glucose core esterified with gallagyl and hexahydroxydiphenoyl groups, and they exist as interconverting alpha and beta anomers.
Punicalagin is too large to be absorbed intact in any meaningful amount; it hydrolyses in the gut to release ellagic acid, which colonic bacteria then dehydroxylate stepwise to urolithins.
Urolithin production is a property of a person's gut microbiota, not of a human enzyme, so people fall into different metabotypes and some produce very little urolithin from the same intake.
As a polyphenol with many adjacent phenolic hydroxyls, punicalagin binds divalent metal cations and precipitates proteins, the two interactions that govern how it behaves in a mixed formulation.
Where Punicalagins (Pomegranate) comes from.
Pomegranate peel is soaked in water or alcohol, the polyphenols are captured on a resin and washed clean, then the concentrate is dried and tested to confirm how much punicalagin the powder holds.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Punica granatum peel and husk carry far more ellagitannin than the arils, so peel is the usual feedstock for a standardised extract.
Milled peel is extracted with water or an ethanol and water mixture, in which the hydrolysable tannins are readily soluble.
The extract is passed over an adsorbent resin to hold the polyphenols while sugars and acids are washed away, then eluted.
The dried powder is assayed by HPLC for punicalagin alpha and beta and blended to a declared percentage.
Concentrate is spray dried, often onto a carrier, to give a free-flowing powder for capsules or tablets.
Getting Punicalagins (Pomegranate) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Reviewing the human trials, pomegranate intake was most consistently linked with lower blood pressure and improved blood lipid and blood sugar measures in adults with metabolic risk markers.Systematic review. Laurindo et al., 2022 (Nutrients). PMID 35458227 ↗
- In adults aged 55 to 70, pomegranate extract lowered several circulating inflammatory markers and improved some cardiometabolic measures against placebo.Randomised trial. Farhat et al., 2025 (Nutrients). PMID 40218993 ↗
- The same trial population showed changes in IGF-1 levels with pomegranate extract, while no difference in telomere length was detected against placebo.Randomised trial. Farhat et al., 2025 (Nutrients). PMID 41010500 ↗
- The authors identify punicalagin as the constituent responsible for the antimicrobial activity of the extract they tested, measured against microbial cultures in the laboratory.In vitro study. Salim et al., 2025 (Journal of Agricultural and Food Chemistry). PMID 40629888 ↗
- A systematic review of pomegranate preparations used alongside standard care in adults; the material reviewed is whole pomegranate rather than isolated punicalagin, and the review reports the available trials as small and varied.Systematic review. de Carvalho et al., 2026 (Clinical Nutrition ESPEN). PMID 41265522 ↗
- Antioxidant plus energy supplementation reduced markers of oxidative stress and was associated with higher milk output in the animals studied; oxidative-stress markers here are markers, not clinical outcomes, the milk finding is an association, and the species is not human.Animal study. Ahmadpour et al., 2026 (Tropical Animal Health and Production). PMID 41615559 ↗
These are the studies our verdict leans on, chosen from the 153 we read for Punicalagins (Pomegranate). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.